In cancer pain management, what is the purpose of breakthrough dosing within the WHO ladder framework?

• A. To replace scheduled dosing entirely.
• B. To eliminate the need for non-opioids.
• C. To provide additional short-acting analgesia for transient pain flares between scheduled doses.
• D. To prove that opioids are ineffective.

Answer: (C)

Breakthrough dosing is used to manage transient spikes of pain that occur even when a regular, around-the-clock analgesic regimen is in place. In the WHO ladder approach, the goal of scheduled dosing is to maintain a steady level of pain control, while breakthrough doses provide short-acting relief for sudden flares between those scheduled doses. These fast-acting doses are usually short-acting opioids and are given as needed to quickly blunt the breakthrough pain, helping maintain overall comfort and function.

This approach doesn’t replace the scheduled regimen, and non-opioids or adjuvants still play a role in the baseline plan. It also isn’t about proving opioids are ineffective; it’s about providing flexible, responsive analgesia to cover episodic pain while keeping the regular regimen intact.